Muhammad bin Youssef Al-Mazyad takes advantage of his free time to browse "Okaz", noting that it is the best publication that he is keen to read to develop his writing skills, in addition to its diversity, credibility and comprehensiveness.
Read next
A Generation Is Damaging Its Hearing and Will Not Know for Decades
Personal audio at high volume for hours a day is producing hearing loss that accumulates silently.
Clinical Trials Accelerate Integration of Synthetic Control Arms
Pharmaceutical firms are leveraging historical patient datasets to construct synthetic control arms, significantly reducing phase II clinical trial…
GLP-1 Weight-Loss Therapeutics Reshape Pharmaceutical Supply Chains
High demand for metabolic treatments creates manufacturing constraints and disrupts corporate wellness programs.
GLP-1 Class Therapies Expand into Cardiovascular Disease Treatment
Clinical trial results demonstrate significant reductions in adverse cardiac events among non-diabetic patients using GLP-1 receptor agonists.
Clinical Trials Accelerate for AI-Designed Small Molecule Inhibitors
Pharmaceutical developers report accelerated candidate selection phases as machine learning models streamline compound discovery.
AI-Driven Clinical Trial Design Reduces Pharmaceutical R&D Timelines
Predictive patient stratification tools trim Phase II trial durations by up to 30 percent, shifting drug discovery economics.